| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 16 sells. REPL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 533.6K | $5.97M | - | |
| Other | 201.6K | $2.25M | - | |
| Other | 199.7K | $2.23M | - | |
| CFO | 194.4K | $2.17M | - | |
| Other | 78.3K | $875.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2020 | Love Colin72 | Chief Operating Officer | Sell | 15,000 | $44.91 | $673,648.83 | -0.5% | |
| Oct 14, 2020 | Esposito Pamela71 | Chief Business Officer | Sale+OE | 16,000 | $32.90 | $526,410.00 | -6.4% | |
| Sep 15, 2020 | Love Colin72 | Chief Operating Officer | Sell | 15,000 | $23.97 | $359,486.88 | -0.5% | |
| Aug 31, 2020 | Esposito Pamela71 | Chief Business Officer | Sale+OE | 5,000 | $27.05 | $135,250.00 | -4.2% | |
| Aug 17, 2020 | Love Colin72 | Chief Operating Officer | Sell | 15,000 | $23.44 | $351,554.76 | -0.7% | |
| Jul 9, 2020 | Coffin Robert61 | President &Chief R&D Officer | Sell | 169,750 | $22.13 | $3,757,295.00 | -4.0% | |
| Feb 20, 2020 | Coffin Robert61 | Pres &Chief Res &Dev Officer | Sell | 24,250 | $17.04 | $413,220.00 | -1.1% | |
| Feb 12, 2020 | Coffin Robert61 | Pres &Chief Res &Dev Officer | Sell | 48,500 | $17.04 | $826,197.50 | -1.1% | |
| Nov 18, 2019 | Omega Fund Iv, L.P.81 | 10% Owner | Buy | 220,000 | $13.61 | $2,994,200.00 | +4.3% | |
| Nov 18, 2019 | Rhodes Jason P78 | Director | Buy | 1,100,000 | $13.61 | $14,971,000.00 | New |